- intermediates and API manufacturing of antibiotic drugs, cardiovascular drugs, diabetes drugs & anti-tumor drugs
- other drugs api manufacture
- Anti cardiovascular and cerebrovascular diseases drugs api manufacture
- Cephalosporins api manufacture
- Anti-Diabetic Drugs Api and Intermediates Manufacture
- 404 - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Join Us - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Veterinary Drugs Manufacture
- Culture - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Shandong Sihuan Pharmaceutical Co., ltd Contact
- Organization Chart - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Anti-Tumor intermeidates and API Manufacture
- News - Shandong Sihuan Pharmaceutical Co.,Ltd.
- News - Shandong Sihuan Pharmaceutical Co.,Ltd.
- News - Shandong Sihuan Pharmaceutical Co.,Ltd. page 3
- News - Shandong Sihuan Pharmaceutical Co.,Ltd. page 4
- News - Shandong Sihuan Pharmaceutical Co.,Ltd. page 5
- News - Shandong Sihuan Pharmaceutical Co.,Ltd. page 6
- Corporate Image - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Anti-Inflammatory API and Intermediates Manufacture
- Products - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Products - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Products - Shandong Sihuan Pharmaceutical Co.,Ltd. page 3
- Technology - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Anti-Platelet Coagulation API and Intermediates Manufacture
- antibiotic, cardiovascular, diabetes, anti-tumor drugs API and Intermediates Manufacture
- Qualification - Shandong Sihuan Pharmaceutical Co.,Ltd.
- Antiviral API Tenofovir Alafenamide Fumarate
- Industry News-Shandong Sihuan Pharmaceutical Co.,Ltd.
- Industry News-Shandong Sihuan Pharmaceutical Co.,Ltd.
- Industry News-Shandong Sihuan Pharmaceutical Co.,Ltd. page 3
- Industry News-Shandong Sihuan Pharmaceutical Co.,Ltd. page 4
- Health Care
- Company News-Shandong Sihuan Pharmaceutical Co.,Ltd.
- Company News-Shandong Sihuan Pharmaceutical Co.,Ltd.
- Product (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate
- Product 2-(3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl
- Product 4,6-dichloro-2-propylthiopyrimidine-5-amine
- Product Tenofovir Alafenamide Fumarate
- Product Pyrroloquinolinequinone disodium salt
- Product Cetilistat
- Product Nicotinamide riboside chloride
- Product Name: β-Nicotinamide Mononucleotide/NMN
- Product (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(tert-butoxycarbonyl)amino)-2-methylpentanoic acid
- Product (R,E)-5-([1,1'-biphenyl]-4-yl)-4-(tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoic acid
- Product Sacubitril Calcium salt
- Product Sacubitril valsartan /LCZ696
- LCZ696 InteMediate
- Ethyl 2-(triphenylphosphoranylidene)propionate
- 2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic Acid Ethyl Ester Hydrochloride
- Product 4-Methylthiazole-5-carboxaldehyde
- Product 7-AMCA
- Product Cefpodoxime
- Product Cefodizime sodium
- Product Boc-Cefcapene.DIPA
- Product 2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid
- Product Cefapirin sodium
- Product (6R,7R)-7-Amino-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Product Cefteram pivoxil
- Product Cefteram pivoxil
- 6R,7R)-7-Amino-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Product 7-7-TDA
- Product Cefazedone
- Product Cefmenoxime hydrochloride
- Product Cefcapene pivoxil hydrochloride
- Sulbenicillin sodium
- Nafcillin sodium salt monohydrate
- 2-ETHOXY-1-NAPHTHALDEHYDE
- Alpha-Sulfophenylacetic acid
- 7-TMCA
- 5-Methyl-1H-tertazole
- 4-Hydroxy-6-methylnicotinic acid
- 4-Methylthiazole-5-carboxaldehyde
- 3,5-Dichloro-4-pyridone-N-acetic acid
- 2-ETHOXY-1-NAPHTHOIC ACID
- 2-HYDROXY-1-NAPHTHOIC ACID
- 2-Hydroxy-1-naphthaldehyde
- Product (R)-3-(Boc-Amino)piperidine
- Product Benzonitrile,2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]
- Product 2-(chloromethyl)-4-methylquinazoline
- Product 2-Cyanobenzyl bromide
- Product 3-METHYLXANTHINE
- Product 6-Chloro-3-methyluracil
- Product 8-Bromo-3-methyl-xanthine
- Product 8-Bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione
- Product Alogliptin benzoate
- Product Linagliptin
- Product 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
- Product Trelagliptin succinate
- Product Empagliflozin
- Dapagliflozin
- 5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone
- Acetoxy Empagliflozin
- Tert-butyl(3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-(4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-, tetraacetate, (1S)-
- Finerenone
- Dapagliflozin propanediol monohydrate
- R)-3-Piperidinamine dihydrochloride
- R)-3-(Boc-Amino)piperidine
- 5-bromo-2-chloro-4’-ethoxydiphenylmethane
- 1-BROMO-2-BUTYNE
- Product CEPHAPIRIN BENZATHINE
- Ceftiofur hydrochloride
- Ceftiofur sodium
- Product 2-Hydroxy-1-naphthaldehyde
- Product 2-HYDROXY-1-NAPHTHOIC ACID
- Product 2-ETHOXY-1-NAPHTHOIC ACID
- Product 3,5-Dichloro-4-pyridone-N-acetic acid
- Product 3,5-Dichloro-4-hydroxypyridine
- Product 4-Hydroxy-6-methylnicotinic acid
- Product 4-Hydroxypyridine
- Product 5-Methyl-1H-tertazole
- Product 7-TMCA
- Product Alpha-Sulfophenylacetic acid
- Product 2-ETHOXY-1-NAPHTHALDEHYDE
- Product Creatine phosphate disodium salt
- Product Nafcillin sodium salt monohydrate
- Product Tianeptine
- Lemborexant
- 5-Pyrimidinol, 2,4-dimethyl- (9CI)
- Atracurium besylate
- Clascoterone
- 1,2-Cyclopropanedimethanol, 1-(3-fluorophenyl)-, 2-acetate 1-(4-methylbenzenesulfonate), (1S,2R)-
- Myosmine
- 5-Pyrimidinol, 2,4-dimethyl- (9CI)
- Lemborexant
- Cortexolone
- 4-(3'-Methylphenyl)amino-3-pyridinesulfonamide
- 5-Hydroxy-1H-imidazole-4-carboxamide
- BISOXATIN ACETATE
- 3-Bromopropionaldehydedimethylacetal
- 4-AMino-5-Methylpyridin-2-ol
- 3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran
- 4-Cyano-2-methoxybenzaldehyde
- Prucalopride Succinate
- 4-Nitrophenethylamine hydrochloride
- Mirabegron
- Idebenone
- Product AZD3759
- Product N,N,N'-TRIMETHYLETHYLENEDIAMINE
- Product Brigatinib
- Product Niraparib Tosylate
- Product Veliparib
- Product Veliparib dihydrochloride
- Product Ibrutinib
- 2,5-dichloro-N-(2-(diMethylphosphoryl)phenyl)pyriMidin-4-aMine
- 4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate
- AMG 510
- MRTX-849
- Osimertinib mesylate
- Lorlatinib
- Product 4-(1H-PYRAZOL-4-YL)-7-(2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE
- Product Baricitinib
- Product Tofacitinib citrate
- Product Nafamostat Mesylate
- Product Baloxavir marboxil
- Molnupiravir
- L-Valine, 3-methyl-N-(trifluoroacetyl)- (9CI)
- 3aR,4R,6R,6aR)-6-(E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
- Pyrrolo[1,2-F][1,2,4]triazin-4-amine
- 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine
- Remdesivir impurity2
- 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine
- Pyrrolo[1,2-F][1,2,4]triazin-4-amine
- R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione
- 2-(2-(4-methylthiazol-5-yl)ethoxy)-2-oxoethyl)triphenylphosphonium bromide
- 2-(2-(4-methylthiazol-5-yl)ethoxy)-2-oxoethyl)triphenylphosphonium bromide
- β-Nicotinamide Mononucleotide
- Ethyl 6-amino-5-methoxyindole-2-carboxylate
- 2-(2-(4-methylthiazol-5-yl)ethoxy)-2-oxoethyl)triphenylphosphonium bromide
- Nicotinamide riboside malate
- L-Carnosine
- 2017CPHI
- 2017 India CPHI
- 2018 Shanghai CPHI
- Exhibitions in 2018
- 2019 CHPI Exhibition in Shanghai
- 2019 CPHI Exhibition in India
- CPHI
- Shandong Sihuan Pharmaceutical Co., Ltd. was recognized as Dezhou Anti-Diabetic Drug Engineering Research Center!
- 走访困难职工 真情暖人心
- 山东天铭医药集团 山东四环药业股份有限公司 邀您共赴2024 CPHI China 沪上之约
- 喜报!广西天铭药业有限公司获得“国家高新技术企业”认定
- 喜讯|山东四环药业获得平原县“企业环境保护先进单位”荣誉称号
- China rejects patent on hepatitis C drug sofosbuvir
- The listing application is approved by CFDA Boehringer Ingelheim blockbuster drug diethylsulfonate nidanibu soft capsule
- Li Gang, Chairman of Sihuan Pharmaceutical Co., Ltd. , visits Bangladesh
- Discovery of kidney cancer driver could lead to new treatment strategy
- Mid 2018 – Recap of Warning Letters, Import Alerts and Non-Compliances
- India watching China’s measures to ease drug-import norms
- EU expands look at Zhejiang Huahai as impurities show up in other 'sartans'
- China smacks 48 officials, including ex-FDA official, in Changsheng vaccine scandal
- Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
- Nubeqa® (darolutamide) receives EU approval as a new treatment for men with non-metastatic castration-resistant prostate cancer
- Velipanib is a PARP inhibitor for the treatment of ovarian cancer
- To Treat The New Crown, This Medicine Is Cheap And Easy To Use!
- The Special Effects Route To The Anti-Singaporean Crown - Palo Verde
- Shakubatril valsartan brings change to hypertension treatment
- Explanation of Drug Mechanism | Remdesivir, the "People's Hope" antiviral drug
- A new treatment option for ALK-positive lung cancer patients with the approval of Bugatinib tablets
- PQQ: Mitochondrial Optimizer
- Heavyweight! Significant benefit of engramine for CKD, phase III EMPA-KIDNEY trial meets endpoints
- NMN、PQQ、麦角硫因,究竟谁能坐上抗衰界的头把交椅?